Health Canada has the expertise in regulations. Internationally, medium-sized countries do not have enough capacity to conduct research and clinical trials, and so on. It's about expertise—
It's really important to ensure that. The countries that have the highest rates of HIV, where clinical trials will be most able to demonstrate a benefit, or not, also do not have much in the way of regulatory capacity. The ability to assist them to have more uniform standards—that the kinds of standards in these countries and our country are more similar across countries—to facilitate the research, and then ultimately facilitate the ability to provide vaccines is a very important component. It fits very well with the initiative itself.
Glenda may want to add to that.